Healthcare - Medical - Diagnostics & Research - NYSE - US
$ 127.07
-2.42 %
$ 36.5 B
Market Cap
27.27
P/E
CASH FLOW STATEMENT
1.77 B
OPERATING CASH FLOW
-310 M
INVESTING CASH FLOW
-930 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Agilent Technologies, Inc.
| Net Income | 1.24 B |
| Depreciation & Amortization | 271 M |
| Capital Expenditures | -298 M |
| Stock-Based Compensation | 111 M |
| Change in Working Capital | -116 M |
| Others | 278 M |
| Free Cash Flow | 1.47 B |
Cash Flow
Millions
| Oct-2023 | Oct-2022 | Oct-2021 | Oct-2020 | Oct-2019 | Oct-2018 | Oct-2017 | Oct-2016 | Oct-2015 | Oct-2014 | Oct-2013 | Oct-2012 | Oct-2011 | Oct-2010 | Oct-2009 | Oct-2008 | Oct-2007 | Oct-2006 | Oct-2005 | Oct-2004 | Oct-2003 | Oct-2002 | Oct-2001 | Oct-2000 | Oct-1999 | Oct-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||||||||||||
| Net Income | 1 240.0 | 1 254.0 | 1 210.0 | 719.0 | 1 071.0 | 316.0 | 684.0 | 460.0 | 398.0 | 497.0 | 724.0 | 1 153.0 | 1 012.0 | 624.0 | (31.0) | 693.0 | 638.0 | 3 307.0 | 141.0 | 349.0 | (2 058.0) | (1 022.0) | (478.0) | 757.0 | 512.0 | 257.0 |
| Depreciation & Amortization | 271.0 | 317.0 | 321.0 | 308.0 | 238.0 | 210.0 | 212.0 | 246.0 | 253.0 | 383.0 | 372.0 | 301.0 | 253.0 | 202.0 | 162.0 | 201.0 | 191.0 | 170.0 | 186.0 | 292.0 | 362.0 | 735.0 | 734.0 | 495.0 | 475.0 | 477.0 |
| Deferred Income Tax | (56.0) | 8.0 | 14.0 | 29.0 | (255.0) | (16.0) | 102.0 | 3.0 | 70.0 | (132.0) | 31.0 | (158.0) | 38.0 | (109.0) | 28.0 | (53.0) | (134.0) | (19.0) | (12.0) | (33.0) | 1 071.0 | (664.0) | (94.0) | (59.0) | (12.0) | (140.0) |
| Stock Based Compensation | 111.0 | 125.0 | 110.0 | 83.0 | 72.0 | 70.0 | 60.0 | 58.0 | 54.0 | 96.0 | 84.0 | 74.0 | 72.0 | 66.0 | 71.0 | 82.0 | 94.0 | 94.0 | 9.0 | (21.0) | 0 | 0 | (145.0) | 0 | 0 | 0 |
| Other Operating Activities | 322.0 | 86.0 | (82.0) | 78.0 | 283.0 | 52.0 | (71.0) | 51.0 | (29.0) | 210.0 | 23.0 | 192.0 | 7.0 | 38.0 | 73.0 | 12.0 | 15.0 | (2 633.0) | 306.0 | 58.0 | 391.0 | 205.0 | 1 975.0 | (144.0) | (3.0) | 122.0 |
| Change in Working Capital | (116.0) | (478.0) | (88.0) | (296.0) | (388.0) | 455.0 | (98.0) | (25.0) | (255.0) | (341.0) | (82.0) | (334.0) | (122.0) | (109.0) | 105.0 | (179.0) | 120.0 | (285.0) | 269.0 | (32.0) | 111.0 | 159.0 | (490.0) | (211.0) | (511.0) | 35.0 |
| Cash From Operations | 1 772.0 | 1 312.0 | 1 485.0 | 921.0 | 1 021.0 | 1 087.0 | 889.0 | 793.0 | 491.0 | 713.0 | 1 152.0 | 1 228.0 | 1 260.0 | 712.0 | 408.0 | 756.0 | 969.0 | 634.0 | 899.0 | 663.0 | (144.0) | (498.0) | 1 502.0 | 838.0 | 461.0 | 751.0 |
| INVESTING CASH FLOW | ||||||||||||||||||||||||||
| Capital Expenditures | (298.0) | (291.0) | (189.0) | (119.0) | (156.0) | (177.0) | (176.0) | (139.0) | (98.0) | (207.0) | (195.0) | (193.0) | (188.0) | (119.0) | (128.0) | (154.0) | (154.0) | (185.0) | (139.0) | (118.0) | (205.0) | (301.0) | (881.0) | (824.0) | (434.0) | (410.0) |
| Other Items | (12.0) | (47.0) | (560.0) | (28.0) | (1 434.0) | (527.0) | (129.0) | (99.0) | (302.0) | (25.0) | (53.0) | (2 178.0) | 1 482.0 | (1 052.0) | 114.0 | (245.0) | (302.0) | 1 981.0 | (61.0) | 4.0 | 2.0 | 230.0 | (484.0) | (293.0) | 125.0 | 138.0 |
| Cash From Investing Activities | (310.0) | (338.0) | (749.0) | (147.0) | (1 590.0) | (704.0) | (305.0) | (238.0) | (400.0) | (232.0) | (248.0) | (2 371.0) | 1 294.0 | (1 171.0) | (14.0) | (399.0) | (456.0) | 1 796.0 | (200.0) | (114.0) | (203.0) | (71.0) | (1 365.0) | (1 117.0) | (309.0) | (272.0) |
| FINANCING CASH FLOW | ||||||||||||||||||||||||||
| Common Stock Repurchased | (575.0) | (1 139.0) | (788.0) | (469.0) | (723.0) | (422.0) | (194.0) | (434.0) | (267.0) | (200.0) | (900.0) | (172.0) | (497.0) | (411.0) | (157.0) | (1 001.0) | (1 944.0) | (4 235.0) | (290.0) | 0 | 0 | 0 | 0 | (2 068.0) | 0 | 0 |
| Total Debt Repaid | (35.0) | 26.0 | 356.0 | (120.0) | 600.0 | (693.0) | 110.0 | 262.0 | 0 | 99.0 | 347.0 | 148.0 | (1 500.0) | 718.0 | 748.0 | 16.0 | 589.0 | 1 500.0 | (688.0) | 1.0 | (2.0) | 1 122.0 | (113.0) | 110.0 | 0 | 0 |
| Dividends Paid | (265.0) | (250.0) | (236.0) | (222.0) | (206.0) | (191.0) | (170.0) | (150.0) | (133.0) | (176.0) | (156.0) | (104.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (55.0) | (9.0) | (28.0) | 94.0 | 30.0 | 509.0 | 52.0 | 54.0 | (689.0) | 180.0 | 155.0 | 96.0 | 304.0 | (5.0) | (5.0) | 0 | 0 | (220.0) | 0 | 0 | 0 | 0 | 0 | 1 081.0 | (152.0) | (479.0) |
| Cash From Financing Activities | (930.0) | (1 372.0) | (696.0) | (717.0) | (299.0) | (797.0) | (202.0) | (268.0) | (1 089.0) | (97.0) | (554.0) | (32.0) | (1 693.0) | 604.0 | 657.0 | (774.0) | (980.0) | (2 408.0) | (780.0) | 145.0 | 110.0 | 1 243.0 | 37.0 | 1 275.0 | (152.0) | (479.0) |
| CHANGE IN CASH | ||||||||||||||||||||||||||
| Net Change In Cash | 537.0 | (434.0) | 43.0 | 59.0 | (866.0) | (431.0) | 389.0 | 286.0 | (215.0) | 353.0 | 324.0 | (1 176.0) | 878.0 | 170.0 | 1 074.0 | (421.0) | (436.0) | 36.0 | (89.0) | 708.0 | (237.0) | 674.0 | 174.0 | 996.0 | 0 | 0 |
| FREE CASH FLOW | ||||||||||||||||||||||||||
| Free Cash Flow | 1 474.0 | 1 021.0 | 1 296.0 | 802.0 | 865.0 | 910.0 | 713.0 | 654.0 | 393.0 | 506.0 | 957.0 | 1 035.0 | 1 072.0 | 593.0 | 280.0 | 602.0 | 815.0 | 449.0 | 760.0 | 545.0 | (349.0) | (799.0) | 621.0 | 14.0 | 27.0 | 341.0 |